Simple research view

WAT · Waters Corporation

$401.64 -0.78% Sep 10 close

Detected setup Trend Only · Setup Score 67/100

Stand aside — setup invalidated

Setup score 67, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about WAT

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$WAT

Waters Corporation

Waters Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $39B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 2

$401.64 latest close

⚠ Risk Signals

Bearish RSI Divergence Price higher high ($416.15→$421.26) but RSI lower high (71→65) — momentum diverging

Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.

Join to Watchlist $WAT Share card

Verdict · setup score 67/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 67, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

WAT-0.78%

Sector proxy · XLV-0.55%

Broad market · SPY-0.60%

Same completed session window ending 2026-09-10. WAT was -0.23 points vs XLV. -0.18 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close-0.78% From the open+0.13% Range position82% GapNo gap

QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $401.64 -0.8% Sep 10 close

52W High $426.22 5.8% below high

Wks Since High 1w

Base Depth 4.7% 7.8% today

RS Rank 50 percentile of scan

SMA 50 $393.53

Avg Vol 769,227

Rel Vol (Sep 10) 0.74×

More stats

52W Low $282.77

Tight Wks 0

Base B2

SMA 200 $361.16

RS Line vs High -13.3%

RS Line Slope -0.3% ▼

Group Rank #25/58

ADR% 2.8%

ATR(14) $11.96 (3.0%)

Vol Pace (live) N/A

U/D Vol 1.33

A/D Days 18A / 16D

A/D Rating B

VDU Bars 0/10 d

Position in 52-week range 83rdpercentile of the 52-week range

$282.77low

$426.22high

WAT Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for WAT.

Create Free Account

Technical Analysis Report Card

$WAT · $401.64 · as of 2026-09-10 · multi-factor read

/ 100

Technicals 72/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$393.53 ↑

100-day$370.25 ↑

200-day$361.16 ↑

Bullish (50 > 200)

RSI (14)

Reading47.8 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening

Histogram-2.621

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width10% · 5.2%

Squeeze — volatility compressing

Near the lower band — under pressure or oversold. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.33 · Neutral

Rel volume0.74×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $426.2252-week high

Price · $401.64now

S · $396.00swing level

S · $351.77swing level

S · $345.20swing level

Fibonacci · Uptrend swing

23.6%$393.41

38.2%$373.11

50.0%$356.71

61.8%$340.30

78.6%$316.94

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for WAT — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish

Want this read in a legend's voice? Ask a Legend about WAT

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini D

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $401.64, MA150 $351.57, MA200 $361.16

1.4 50-day MA > 150-day MA AND 200-day MAMA50 $393.53, MA150 $351.57, MA200 $361.16

Failing evidence

1.2 150-day MA > 200-day MAMA150 $351.57 vs MA200 $361.16

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 58

5/10 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high5.8% below high | RS line new high: False

S: Base tightness (ATR% ≤ 4.5%)ATR% 2.98%

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 58

C: Quarterly EPS acceleration ≥ 25%Data unavailable

2/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $401.64 vs MA200 $361.16

Failing evidence

Volume expansion above averageVolume ratio 0.74x

Relative strength ≥ 60RS 58

4/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$401.64

Distance from 52-week high5.8% below high

Failing evidence

Relative strengthRS 58

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$401.64

Distance from 52-week high5.8% below high

Failing evidence

Relative strengthRS 58

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$401.64

Distance from 52-week high5.8% below high

Failing evidence

Relative strengthRS 58

Volume vs average0.74x

3/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 B

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met

C 2/7 criteria

Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY +7%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✗ RS rating ≥80 (leadership) 58

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -5.8%

Method Playbook

Trade it like O'Neil EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.

Pivot

Pro level

Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Trend Only

67 setup score

RS Score 58

Trend template 6/8

Why This Setup? D+W Confluence

Trend Only · schematic

Gatekeeper 6/8 | Moderate trend (6/8) | Stage 2

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met

A relative-strength leader — not met RS rank 50 — laggard
Risk is defined — not met No stop — undefined risk
Asymmetric reward — partly met No target set
Clear of earnings — partly met Report date unknown
Not chasing (in range) — partly met Pivot distance unknown
Volume confirms — partly met 0.7× average — light
In a confirmed uptrend — met Stage 2 · Trend template 6/8

Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $401.64 vs SMA150 $351.57 / SMA200 $361.16

SMA 150 above SMA 200 SMA150 $351.57 vs SMA200 $361.16

SMA 200 trending up Slope +4.33 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $393.53

Price above SMA 50 $401.64 vs SMA50 $393.53

30%+ above 52-week low +42.0% from $282.77

Within 25% of 52-week high -5.8% from $426.22

RS score above 70 RS 58

Fundamentals

52W Range

83%

Mkt Cap SEC

39.5B

Rev YoY

+7%

EPS TTM

$10.76

P/E TTM

37.3x

Float

98M

Company

Company profile

Waters Corporation

WAT · NYSE · Health Technology · Medical Specialties

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

7/8

W. RS

W. Support

$282.77

W. Resist

$426.22

W. Patterns

Cup & Handle

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Sep 11

Trend Only ✓ Gate

Sep 11

Trend Only ✓ Gate

Sep 11

Trend Only ✓ Gate

Sep 10

Wyckoff SOS ✓ Gate

55 0.0%

Sep 09

Trend Only ✓ Gate

62 -0.8%

Get the full picture on WAT

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial